35676488|t|Potentiating adoptive cell therapy using synthetic IL-9 receptors.
35676488|a|Synthetic receptor signalling has the potential to endow adoptively transferred T cells with new functions that overcome major barriers in the treatment of solid tumours, including the need for conditioning chemotherapy1,2. Here we designed chimeric receptors that have an orthogonal IL-2 receptor extracellular domain (ECD) fused with the intracellular domain (ICD) of receptors for common gamma-chain (gammac) cytokines IL-4, IL-7, IL-9 and IL-21 such that the orthogonal IL-2 cytokine elicits the corresponding gammac cytokine signal. Of these, T cells that signal through the chimeric orthogonal IL-2Rbeta-ECD-IL-9R-ICD (o9R) are distinguished by the concomitant activation of STAT1, STAT3 and STAT5 and assume characteristics of stem cell memory and effector T cells. Compared to o2R T cells, o9R T cells have superior anti-tumour efficacy in two recalcitrant syngeneic mouse solid tumour models of melanoma and pancreatic cancer and are effective even in the absence of conditioning lymphodepletion. Therefore, by repurposing IL-9R signalling using a chimeric orthogonal cytokine receptor, T cells gain new functions, and this results in improved anti-tumour activity for hard-to-treat solid tumours.
35676488	229	236	tumours	Disease	MESH:D009369
35676488	451	469	common gamma-chain	Gene	16186
35676488	471	477	gammac	Gene	16186
35676488	489	493	IL-4	Gene	16189
35676488	495	499	IL-7	Gene	16196
35676488	501	505	IL-9	Gene	16198
35676488	510	515	IL-21	Gene	60505
35676488	541	545	IL-2	Gene	16183
35676488	667	676	IL-2Rbeta	Gene	16185
35676488	681	686	IL-9R	Gene	16199
35676488	748	753	STAT1	Gene	20846
35676488	755	760	STAT3	Gene	20848
35676488	765	770	STAT5	Gene	20850
35676488	896	902	tumour	Disease	MESH:D009369
35676488	942	947	mouse	Species	10090
35676488	948	960	solid tumour	Disease	MESH:D009369
35676488	971	979	melanoma	Disease	MESH:D008545
35676488	984	1001	pancreatic cancer	Disease	MESH:D010190
35676488	1099	1104	IL-9R	Gene	16199
35676488	1225	1231	tumour	Disease	MESH:D009369
35676488	1265	1272	tumours	Disease	MESH:D009369
35676488	Positive_Correlation	16185	20848
35676488	Positive_Correlation	16199	20846
35676488	Association	MESH:D009369	16199
35676488	Positive_Correlation	16199	20848
35676488	Positive_Correlation	16199	20850
35676488	Positive_Correlation	16185	20850
35676488	Positive_Correlation	16185	20846
35676488	Association	16185	16199

